LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 513 | 3950 | 10483 | 0.3768 | 0.5982 |
MCF 10A | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 513 | 3868 | 10254 | 0.3772 | 0.5959 |
MCF 10A | Linsitinib | 1.11 | uM | LJP5 | 2 | O21 | 72 | hr | 513 | 3867 | 10349 | 0.3736 | 0.5936 |
MCF 10A | Linsitinib | 1.11 | uM | LJP5 | 3 | O21 | 72 | hr | 513 | 3850 | 10483 | 0.3672 | 0.5888 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 513 | 3478 | 10254 | 0.3392 | 0.5572 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 2 | O20 | 72 | hr | 513 | 2882 | 10349 | 0.2785 | 0.4890 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 3 | O20 | 72 | hr | 513 | 2893 | 10483 | 0.2760 | 0.4878 |
MCF 10A | Linsitinib | 10 | uM | LJP5 | 1 | O19 | 72 | hr | 513 | 1843 | 10254 | 0.1797 | 0.3443 |
MCF 10A | Linsitinib | 10 | uM | LJP5 | 2 | O19 | 72 | hr | 513 | 2144 | 10349 | 0.2072 | 0.3908 |
MCF 10A | Linsitinib | 10 | uM | LJP5 | 3 | O19 | 72 | hr | 513 | 2054 | 10483 | 0.1959 | 0.3752 |
MCF 10A | Ruxolitinib | 0.04 | uM | LJP5 | 1 | O18 | 72 | hr | 513 | 9619 | 10254 | 0.9380 | 0.9706 |
MCF 10A | Ruxolitinib | 0.04 | uM | LJP5 | 2 | O18 | 72 | hr | 513 | 9900 | 10349 | 0.9566 | 0.9796 |
MCF 10A | Ruxolitinib | 0.04 | uM | LJP5 | 3 | O18 | 72 | hr | 513 | 9788 | 10483 | 0.9337 | 0.9687 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 1 | O17 | 72 | hr | 513 | 9805 | 10254 | 0.9561 | 0.9793 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 2 | O17 | 72 | hr | 513 | 9841 | 10349 | 0.9509 | 0.9769 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 3 | O17 | 72 | hr | 513 | 10369 | 10483 | 0.9891 | 0.9950 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 1 | O16 | 72 | hr | 513 | 9488 | 10254 | 0.9252 | 0.9643 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 2 | O16 | 72 | hr | 513 | 9982 | 10349 | 0.9645 | 0.9834 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 3 | O16 | 72 | hr | 513 | 9358 | 10483 | 0.8926 | 0.9485 |
MCF 10A | Ruxolitinib | 1.11 | uM | LJP5 | 1 | O15 | 72 | hr | 513 | 8719 | 10254 | 0.8502 | 0.9263 |
MCF 10A | Ruxolitinib | 1.11 | uM | LJP5 | 2 | O15 | 72 | hr | 513 | 9365 | 10349 | 0.9049 | 0.9544 |
MCF 10A | Ruxolitinib | 1.11 | uM | LJP5 | 3 | O15 | 72 | hr | 513 | 8796 | 10483 | 0.8390 | 0.9210 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 1 | O14 | 72 | hr | 513 | 8520 | 10254 | 0.8308 | 0.9160 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 2 | O14 | 72 | hr | 513 | 9383 | 10349 | 0.9066 | 0.9553 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 3 | O14 | 72 | hr | 513 | 8465 | 10483 | 0.8075 | 0.9041 |